CTPL CSO Dominic Wall comments on opportunities and challenges of CAR-T therapy in lead-up to AusBiotech 2015

September 25th, 2015 | Posted by webmaster in News

Cell Therapies’ Chief Scientific Officer, Dr Dominic Wall will participate in AusBiotech2015 as part of the Regenerative Medicine Forum. He is quoted today in an article by Sue Dunlevy highlighting the opportunities for improved cancer outcomes emerging from CAR-T research and the remaining challenges of manufacturing these patient specific therapies cost effectively. See the full article here: http://www.news.com.au/news/what-if-we-cant-afford-the-cure-for-cancer/story-fnihsrk2-1227542906466

You can follow any responses to this entry through the RSS 2.0 Both comments and pings are currently closed.